Search results
Results from the WOW.Com Content Network
Neonatal Resuscitation Program logo. The Neonatal Resuscitation Program is an educational program in neonatal resuscitation that was developed and is maintained by the American Academy of Pediatrics. [1] This program focuses on basic resuscitation skills for newly born infants. [2]
Ephedrine, one of the most well-known selective NRAs.. A norepinephrine releasing agent (NRA), also known as an adrenergic releasing agent, is a catecholaminergic type of drug that induces the release of norepinephrine (noradrenaline) and epinephrine (adrenaline) from the pre-synaptic neuron into the synapse.
The PALS guidelines comment on this issue: "There are no data regarding the safety or efficacy of adjusting the doses of resuscitation medications in obese patients. Therefore, regardless of the patient’s habitus, use the actual body weight for calculating initial resuscitation drug doses or use a body length tape with pre-calculated doses." [5]
The dose should be increased after a minimum of 3 days up to approximately 1.2 mg/kg daily (target dose) as a single or two divided doses (in the morning and late afternoon). For children older than 6 years old, over 70 kg, acute treatment should be started with 40 mg/day orally and increased up to 80 mg/day after a minimum of 3 days.
Neonatal resuscitation, also known as newborn resuscitation, is an emergency procedure focused on supporting approximately 10% of newborn children who do not readily begin breathing, putting them at risk of irreversible organ injury and death. [1] Many of the infants who require this support to start breathing well on their own after assistance.
Norepinephrine, also known as noradrenaline and sold under the brand name Levophed among others, is a medication used to treat people with very low blood pressure. [2] It is the typical medication used in sepsis if low blood pressure does not improve following intravenous fluids. [3]
The WHO Model List of Essential Medicines for Children (aka Essential Medicines List for Children [1] or EMLc [1]), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe in children up to twelve years of age to meet the most important needs in a health system.
Doses higher than 1 mg of epinephrine are not recommended for routine use in cardiac arrest. If the person has a non-shockable rhythm, such as asystole, following an initial round of CPR, 1 mg of epinephrine should be given every 3–5 minutes, with the goal of obtaining a shockable rhythm.